These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 21361961)
21. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption. Michael H; Härkönen PL; Väänänen HK; Hentunen TA J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275 [TBL] [Abstract][Full Text] [Related]
22. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways. Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253 [TBL] [Abstract][Full Text] [Related]
23. Inhibition of receptor activator of nuclear factor-κB ligand- or lipopolysaccharide-induced osteoclast formation by conophylline through downregulation of CREB. Koide N; Kondo Y; Odkhuu E; Ulziisaikhan J; Ukaji T; Yokochi T; Umezawa K Immunol Lett; 2014 Sep; 161(1):31-7. PubMed ID: 24792671 [TBL] [Abstract][Full Text] [Related]
24. The phosphatidylinositol 3-kinase-mediated production of interferon-beta is critical for the lipopolysaccharide inhibition of osteoclastogenesis. Lee Y; Huang H; Kim HJ; Park CK; Kim HH Life Sci; 2008 Aug; 83(9-10):369-76. PubMed ID: 18675826 [TBL] [Abstract][Full Text] [Related]
25. [Effect of lipopolysaccharide on osteoclasts formation and bone resorption function and its mechanism]. Zeng L; Xu Y; Xing G Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2018 May; 32(5):568-574. PubMed ID: 29806344 [TBL] [Abstract][Full Text] [Related]
26. Anti-IFN-γ Antibody Promotes Osteoclastogenesis in Human Bone Marrow Monocyte-Derived Macrophages Co-Cultured with Tuberculosis-Activated Th1 Cells. Deng J; Sun D; Luo F; Zhang Q; Chen F; Xu J; Zhang Z Cell Physiol Biochem; 2018; 49(4):1512-1522. PubMed ID: 30205409 [TBL] [Abstract][Full Text] [Related]
27. A rapid multiparameter approach to study factors that regulate osteoclastogenesis: demonstration of the combinatorial dominant effects of TNF-alpha and TGF-ss in RANKL-mediated osteoclastogenesis. Huang W; Drissi MH; O'Keefe RJ; Schwarz EM Calcif Tissue Int; 2003 Dec; 73(6):584-93. PubMed ID: 14517717 [TBL] [Abstract][Full Text] [Related]
28. Interleukin-7 is a direct inhibitor of in vitro osteoclastogenesis. Lee SK; Kalinowski JF; Jastrzebski SL; Puddington L; Lorenzo JA Endocrinology; 2003 Aug; 144(8):3524-31. PubMed ID: 12865334 [TBL] [Abstract][Full Text] [Related]
29. Caffeic acid phenethyl ester, an active component of honeybee propolis attenuates osteoclastogenesis and bone resorption via the suppression of RANKL-induced NF-kappaB and NFAT activity. Ang ES; Pavlos NJ; Chai LY; Qi M; Cheng TS; Steer JH; Joyce DA; Zheng MH; Xu J J Cell Physiol; 2009 Dec; 221(3):642-9. PubMed ID: 19681045 [TBL] [Abstract][Full Text] [Related]
30. Oral administration of prostaglandin E(2)-specific receptor 4 antagonist inhibits lipopolysaccharide-induced osteoclastogenesis in rat periodontal tissue. Oka H; Miyauchi M; Furusho H; Nishihara T; Takata T J Periodontol; 2012 Apr; 83(4):506-13. PubMed ID: 21910594 [TBL] [Abstract][Full Text] [Related]
31. Functional role of endogenous CD14 in lipopolysaccharide-stimulated bone resorption. Amano S; Kawakami K; Iwahashi H; Kitano S; Hanazawa S J Cell Physiol; 1997 Dec; 173(3):301-9. PubMed ID: 9369942 [TBL] [Abstract][Full Text] [Related]
32. Effects of vascular endothelial growth factor-C and -D on osteoclast differentiation and function in human peripheral blood mononuclear cells. Motokawa M; Tsuka N; Kaku M; Kawata T; Fujita T; Ohtani J; Matsuda Y; Terao A; Tanne K Arch Oral Biol; 2013 Jan; 58(1):35-41. PubMed ID: 22771550 [TBL] [Abstract][Full Text] [Related]
33. Nirogacestat suppresses RANKL-Induced osteoclast formation in vitro and attenuates LPS-Induced bone resorption in vivo. Chen X; Chen X; Zhou Z; Mao Y; Wang Y; Ma Z; Xu W; Qin A; Zhang S Exp Cell Res; 2019 Sep; 382(1):111470. PubMed ID: 31211955 [TBL] [Abstract][Full Text] [Related]
34. Biochemical events accompanying macrophage activation and the inhibition of colony-stimulating factor-1-induced macrophage proliferation by tumor necrosis factor-alpha, interferon-gamma, and lipopolysaccharide. Vairo G; Royston AK; Hamilton JA J Cell Physiol; 1992 Jun; 151(3):630-41. PubMed ID: 1338337 [TBL] [Abstract][Full Text] [Related]
35. Primary human bone marrow adipocytes support TNF-α-induced osteoclast differentiation and function through RANKL expression. Goto H; Hozumi A; Osaki M; Fukushima T; Sakamoto K; Yonekura A; Tomita M; Furukawa K; Shindo H; Baba H Cytokine; 2011 Dec; 56(3):662-8. PubMed ID: 21963155 [TBL] [Abstract][Full Text] [Related]
36. Icariin inhibits the osteoclast formation induced by RANKL and macrophage-colony stimulating factor in mouse bone marrow culture. Chen KM; Ge BF; Liu XY; Ma PH; Lu MB; Bai MH; Wang Y Pharmazie; 2007 May; 62(5):388-91. PubMed ID: 17557750 [TBL] [Abstract][Full Text] [Related]
37. Lipopolysaccharide from Prevotella nigrescens stimulates osteoclastogenesis in cocultures of bone marrow mononuclear cells and primary osteoblasts. Chung YH; Chang EJ; Kim SJ; Kim HH; Kim HM; Lee SB; Ko JS J Periodontal Res; 2006 Aug; 41(4):288-96. PubMed ID: 16827722 [TBL] [Abstract][Full Text] [Related]
38. Inhibitory effect of minocycline on osteoclastogenesis in mouse bone marrow cells. Nagasawa T; Arai M; Togari A Arch Oral Biol; 2011 Sep; 56(9):924-31. PubMed ID: 21377143 [TBL] [Abstract][Full Text] [Related]
40. Fluvastatin Inhibits Osteoclast Differentiation and Porphyromonas gingivalis Lipopolysaccharide-Induced Alveolar Bone Erosion in Mice. Pokhrel NK; Kim YG; Kim JY; Kim HH; Lee Y J Periodontol; 2017 Apr; 88(4):390-398. PubMed ID: 27858552 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]